10 / 38
General principles
- Do not loss time!
- Change the treatment a little earlier!
- Be careful with peritoneal carcinomatosis!
- Prepare the patient for the next phase!
- CA 19-9 is important but not specific
- Performance status change very, very quickly.
- Simptoms related to treatment response
- Two “neurophathic” drugs.
- Usual dose, scheme modificatios.